European Monitoring Centre for Drugs and Drug Addiction
12
World Health Organisation (WHO)
12
et al.
9
IACAPAP
9
Organización Mundial de la Salud OMS
6
Ministry of Health, Rwanda
5
Organisation Mondiale de la Santé OMS
5
WHO
5
Indian Council of Medical Research (ICMR)
4
Ministry of Health and Social Services (MOHSS)
4
Ministry of Health, Kenya
4
OPAS
4
Organisation mondiale de la Santé
4
Organisation Mondiale de la Santé OMS
4
Pan American Health Organisation PAHO
4
Pan American Health Organization
4
Africa CDC
3
C. Carandang
3
C. Gray
3
Drugs for Neglected Diseases initiative DNDi
3
H. Marval-Ospino
3
United Nations Office on Drugs and Crime
3
Wiedenmayer, K. et al.
3
Africa CDC Centres for Disease Control and Prevention
2
Africa Center for Disease Control and Prevention
2
African Union
2
C. Bachmann
2
Centers for Disease Control and Prevention CDC
2
European Union
2
International Pharmaceutical Federation
2
Ministerio de Salud Argentina
2
Ministerio de Salud Chile
2
Ministerio de Salud Pública y Bienestar Social Paraguay
2
Ministry of Health and Sanitation Sierra Leone
2
Ministry of Health, Gabarone, Botswana
2
National Centre for Disease Control (NCDC)
2
National Vector Borne Disease Control Programme (NVBDCP)
2
Organisation de la Santé Mondiale
2
Organización Mundial de Saude and OPAS
2
Pharmacy Board Sierra Leone
2
Republic of Kenya, Ministry of Health
2
Robert-Koch-Institut RKI
2
S. MacPhee
2
T. Lempp
2
United Nations
2
United Nations Office on Drug and Crime UNODC
2
Zambia Medicines Regulatory Authority (ZAMRA)
2
2012
1
2016
1
A. K. Lam
1
A. Martin
1
A. Smajljaj
1
A. Sondheimer
1
A. Sönnerborg
1
A. Xhuvani
1
A.Ramesh
1
Abdulrahim, D.
1
ACCSI, et al.
1
Adrian Sondheimer
1
Agence Japonaise de Cooperation International Kokusai Kogyo Co., Ltd.
1
Agency for Toxic Substances & Disease Registry
1
AIEPI Hospitalario
1
American Chemistry Council
1
and O. Bowden-Jones
1
ANDEMIA
1
Australian National Clinical Evidence Taskforce
1
Bălă, G.P.
1
Berkley, James A.
1
BioNTech
1
Bolivia, Ministerio de Salud, Gobierno de Estado Plurinacional s
1
Breitner-Busch, S.
1
Bundeszentrale für gesundheitliche Aufklärung
1
Burri, E.
1
Butkus, R. A.
1
Butterworth Heinemann
1
C. Giannou, M. Baldan and A. Molde
1
C. Kalpaki, M. Moudatsou, E. Maraki, et al.
1
Centers for Disease Control and Prevention (CDC)
1
Centre Anti Poison du Maroc
1
Centre d’excellence Africain pour la santé de la Mère et de l’enfant (CEA-SAMEF)
1
Centre for Antibiotic Resistance Research (CARe), University of Gothenburg
1
Chatanga, Peter
1
Chișinău
1
CODEVIDA, Coalición de Organizaciones por el Derecho a la Salud y a la Vida
1
Congressional Research Service
1
Cordner, S.
1
Cureus
1
D. de Lange, D. Radeloff
1
D. Raben
1
D. Radeloff
1
D.de Lange
1
Dadvand, P.
1
Damialis, A.
1
DATER House
1
David P.M., Le Dévédec N. et al.
1
Dermatol Venez, Univerisdad Central de Venezuela
1
Deutsche Hauptstelle für Suchtfragen e.V.
1
Dilys Morgan, Hilary Kirkbride and Bengü Said
1
Directorate General of Health Services Ministry of Health & Family Welfare Government of the People’s Republic of Bangladesh
1
Dove Medical Press Limited
1
Dr. X. Zeka
1
Drug Safety Monitoring Programme
1
Drugs Advisory Board, Republic of Botswana (Gabarone, Botswana)
1
DTG
1
E. Gjergji
1
E. Subata
1
Elsevier Ltd.
1
EMCDDA
1
Environmental Science and Pollution Research
1
et al
1
Europäische Beobachtungsstelle für Drogen und Drogensucht (EMCDDA)
1
European Centre for Disases Prevention and Control ECDC
1
European Scientific Journal
1
EXPERT REVIEW OF ANTICANCER THERAPY2020, VOL. 20, NO. 4, 271–278
1
F. Fezeu
1
F. S.Sarfo, M. Sarpong Duah, et al.
1
Fairlamb, A.H.
1
Federal Ministries of Agriculture, Environment and Health
1
Ferreira Alves, D.
1
Food and Agriculture Organization (FAO)
1
Food and Agriculture Organization of the United Nations (FAO), World Health Organization (WHO)
1
Food and Agriculture Organization of the United Nations FAO
1
Food and Drug Authority (FDA), Ghana
1
Food and Drugs Authority (FDA), Ghana
1
Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA)
1
Frank, A.
1
Frewer, A.
1
Friedman, J.F. et al.
1
Frimpong, M.
1
Fuller, R.
1
Gascon M., Markevych I.
1
GBD 2019 Blindness and Vision Impairment Collaborators
1
GBD 2019 Tuberculosis Collaborators
1
GBD2019 Dementia Forecasting Coolaborators
1
Global smart
1
Gobierno Bolivariano de Venezuela, UNICEF, et al.
1
Government of India, Ministry of Chemicals & Fertilizers, Department of Pharmaceuticals
1
Government of Kenya
1
Government of South Africa
1
Government of Tanzania
1
Gutiéerrez, J.
1
Gutiérrez, J.
1
H. Furtmayr, K. Krása
1
Haywood, A. and B. D Glass
1
Health Care without Harm
1
Horn, D.
1
Human Rights Watch
1
ICF International
1
ICRC
1
IFRC
1
Indian Council for Medical Research (ICMR)
1
Indian Council of Medical Research (ICMR) & Department of Biotechnology
1
Instituti Shendetit Public
1
International Bureau for Epilepsy
1
International Committee of the Red Cross ICRC
1
International Dairy Federation
1
International Federation of Medical Students’ Associations (IFMSA)
1
International League against Epilepsy
1
International Pharmaceutical Federation FIP
1
Iosue, S.
1
J Pharm Pharm Sci
1
J. M. Rey. M. Irarrázaval
1
J. O. Errecalde
1
J. Sekulić
1
J.-J. Kim
1
Jackson, J., Kheng Heng, L., Eklund, G. et al.
1
Joseph M Rey
1
Journal of Health Monitoring
1
Kadam. A.
1
Katrin Leitmeyer
1
Kingdom of Swaziland Ministry of Health
1
Koren, H.
1
L'avoisier
1
L. Savikj
1
L.R. Cruz
1
Laboratorio Central de Salud Publica
1
Liberia Medicines and Health Products Regulatory Authority (LMHRA)
1
Lisa Myers, Laura Theytaz-Bergman
1
M. Hodaj
1
M. Vitoriaa
1
M.C. Mollo, et al.
1
Mapako, Tonderai, Simbarashe Rusakaniko, Maarten J. Postma, Marinus van Hulst, Janet Dzangare, Stellah Ngwende, John Mandisarisa, Ponesai Nyika, David A. Mvere, Owen Mugurungi, and Mufuta Tshimanga
1
Marie-Noel Bruné Drisse and Fiona Goldizen
1
Mario R Dal Poz, Neeru Gupta, Estelle Quain and Agnes LB Soucat
Para la elaboración de este documento, el grupo de farmacovigilancia de la Red Panamericana para la Armonización Farmacéutica (PARF) se basó en la perspectiva de la OPS/OMS, que considera que la farmacovigilancia es un componente esencial de los programas d...e salud pública (3). Se trabajó con la intención de facilitar el desarrollo de sistemas de farmacovigilancia en las Américas, así como su mejoramiento y fortalecimiento, y promover la
adopción de buenas prácticas para aumentar la seguridad del paciente y de la población, de acuerdo con las necesidades de la región.
Este documento también está disponible en Inglés y Portugués.more
Antimicrobial resistance (AMR) is a global threat that requires urgent
collaborative action within and among countries. As a result of the worldwide reports of the increasing rates of AMR to hospital and community-acquired infections and in the agricultural sector, the Global Action Plan on AMR was... adopted in 2015. Tmore
This is the first NAP on the Prevention and Containment of AMR in Kenya. It has been developed based on the National Policy on Prevention and Containment of AMR and the recommendations of the situation analysis on AMR conducted in 2011 and updated in 2016. This strategy provides a regulatory and imp...lementation framework to establish and strengthen systems to contain the emergence and spread of AMR. Implementation of this strategy will require substantial funding and high-level political commitment. Because AMR is a multidisciplinary and intersectoral issue, successful implementation of this strategy will require effective coordination and collaboration among different sectors.more
This report summarizes the latest scientific knowledge on the links between exposure to air pollution and adverse health effects in children. It is intended to inform and motivate individual and collective action by health care professionals to prevent damage to children’s health from exposure to ...air pollution.
Air pollution is a major environmental health threat. Exposure to fine particles in both the ambient environment and in the household causes about seven million premature deaths each year. Ambient air pollution alone imposes enormous costs on the global economy, amounting to more than US$ 5 trillion in total welfare losses in 2013.
This public health crisis is receiving more attention, but one critical aspect is often overlooked: how air pollution affects children in uniquely damaging ways. Recent data released by the World Health Organization (WHO) show that air pollution has a vast and terrible impact on child health and survival. Globally, 93% of all children live in environments with air pollution levels above the WHO guidelines (see the full report, Air pollution and child health: prescribing clean air. More than one in every four deaths of children under 5 years of age is directly or indirectly related to environmental risks. Both ambient air pollution and household air pollution contribute to respiratory tract infections that resulted in 543 000 deaths in children under the age of 5 years in 2016.more
"This Code provides practical guidance on how to manage health and safety risks associated with hazardous
chemicals for persons conducting a business or undertaking who use chemicals in their workplace."
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...1 to 784 million by 2045.1 As cases rise, it is imperative to ensure the healthcare workforce is prepared to care for affected individuals. However, there is a growing global shortage of healthcare workers, which was estimated, pre pandemic, to reach 15 million by 2030.2 Therefore, all of the healthcare workforce will need to be utilised to their fullest potential in order to address the growing global burden of diabetes. Pharmacists will continue to be essential in this endeavour.more
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
Esta publicación presenta la Agenda para las Américas sobre salud, medioambiente y cambio climático 2021-2030. Esta agenda es un llamamiento al sector de la salud para que lidere la labor a fin de abordar los determinantes ambientales de la salud en la Región de las Américas. La Organización P...anamericana de la Salud (OPS) colaborará con sus Estados Miembros para alcanzar el propósito y el objetivo de esta agenda de promover el bienestar de todos a todas las edades, utilizando un enfoque sostenible y equitativo en el que se otorgue prioridad a la reducción de las inequidades en la salud. La agenda se ha elaborado bajo la égida de la Estrategia mundial de la OMS sobre salud, medio ambiente y cambio climático, y se basa en los compromisos establecidos en la Agenda de Salud Sostenible para las Américas 2018-2030 y el Plan Estratégico de la OPS 2020-2025. La agenda se elaboró en consulta con el grupo técnico asesor y mediante un proceso de toma de decisiones basado en el consenso con los Estados Miembros durante el período 2019-2020. Con la finalidad de alcanzar el Objetivo de Desarrollo Sostenible 3, la agenda se centra en: mejorar el desempeño de los programas e instituciones de salud pública ambiental; fomentar sistemas de salud sostenibles y resilientes desde el punto de vista medioambiental; y promover ciudades y comunidades saludables y resilientes desde el punto de vista medioambiental. Su aplicación será específica para cada contexto y se basará en las necesidades y realidades de los diversos países. Beneficiará a los países y territorios al promover prácticas de buena gobernanza, fortalecer el liderazgo y la coordinación en el sector de la salud, fomentar la acción intersectorial, centrarse en la prevención primaria, y mejorar la evidencia disponible y la comunicación. Facilitará el acceso a los recursos humanos, técnicos y financieros necesarios para abordar los determinantes ambientales de la salud y garantizará que la Región se involucre plenamente en los procesos y acuerdos mundiales sobre salud, medioambiente y cambio climático.more
Indoor residual spraying (IRS) involves applying residual insecticide to potential vector resting sites on the interior surfaces of human dwellings or other buildings. The main aim of IRS is to kill vectors before they are able to transmit pathogens to humans. When carried out correctly, IRS has his...torically been shown to be a powerful intervention to reduce adult vector density and longevity for mosquitoes, sand flies and triatomine bugs and can reduce the transmission of vector-borne diseases.more
Accessed on 29.01.2020
La volonté du CEA-SAMEF à développer des programmes de formation de qualité et des domaines de compétences ciblées a rendu nécessaire l’adoption de référentiels aux exigences internationales. Dans la mise en œuvre de son programme d’accréditation, le CEA-SA...MEF a procédé à l’alignement de son offre de formation aux référentiels nationaux, régionaux et internationaux, de façon à rendre éligibles les programmes à l’accréditation.more
Severe acute respiratory infections treatment centre: practical manual to set up and manage a SARI treatment centre and a SARI screening facility in health care facilities
En esta obra se presentan mensajes básicos para pasar a la acción, resumidos
en una serie de capítulos sobre diversos temas ligados a la salud ambiental,
consultables en línea en: http://www.who.int/ceh/publications/hehc_booklet/en/
index.html